Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells
Article 2008 en
Authors
IV
Ilio Vitale
LS
Laura Senovilla
LG
Lorenzo Galluzzi
Abstract
1 min read
AbstractWe have previously shown that tetraploid cancer cells succumb through a p53-dependent apoptotic pathway when checkpoint kinase 1 (Chk1) is depleted by small interfering RNAs (siRNAs) or inhibited with 7-hydroxystaurosporine (UCN-01). Here, we demonstrate that the Chk1 inhibition results in the activating phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK). Depletion of p38 MAPK by transfection with a siRNA targeting the α isoform of p38 MAPK (p38α MAPK) abolishes the phosphorylation of p53 on serines 15 and 46 that is induced by Chk1 knockdown. The siRNA-mediated downregulation and pharmacological inhibition of p38α MAPK (with SB 203580) also reduces cell death induced by Chk1 knockdown or UCN-01. These results underscore the role of p38 MAPK as a pro-apoptotic kinase in the p53-dependant pathway for the therapeutic elimination of polyploidy cells.
Ilio Vitale, Lorenzo Galluzzi, Sonia Vivet, Lisa Nanty, Laura Senovilla, Ken A. Olaussen, Vladimir Lazar, Roy M. Golsteyn, Maria Castedo, Guido Guido Kroemer
Ilio Vitale, Lorenzo Galluzzi, Sonia Vivet, Lisa Nanty, Philippe Dessen, Laura Senovilla, Ken A. Olaussen, Vladimir Lazar, Michelle Prudhomme, Roy M. Golsteyn, Maria Castedo, Guido Guido Kroemer
Ilio Vitale, Mohamed Jèmaà, Laura Senovilla, Lorenzo Galluzzi, Santiago Rello‐Varona, Didier Métivier, Hugues Ripoche, Vladimir Lazar, Philippe Dessen, Maria Castedo, Guido Guido Kroemer
Discussion(0)
No comments yet. Be the first to comment.